Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Clin Chem Lab Med. 2011 Jul;49(7):1177-85. doi: 10.1515/CCLM.2011.200.
Since the early 1960s, quantitative amino acid analysis (AAA) has traditionally been performed using ion-exchange chromatography with post-column ninhydrin derivatization. This established technology has many advantages, including relatively low cost of operation and ease of use. However, analysis times of 120+ min and high maintenance requirements make this technology unsuitable for the modern clinical laboratories with a requirement for rapid turnaround times. The work described here is a summary of our experiences with a new approach to full profile analysis of physiological amino acids.
Amino acids were derivatized in batches with a proprietary reagent, AccQTag®, which reacts with primary and secondary amines. The derivatized amino acids were separated using Ultraperformance® Liquid Chromatography (UPLC). In a prospective method comparison, quantitative plasma amino acid data obtained from approximately 170 patient samples using both the UPLC method and a traditional ion-exchange chromatography amino acid analyzer were evaluated.
The data obtained from the two methods were found to agree well. Correlation coefficients for the most important amino acids seen in inborn errors of metabolism, such as phenylalanine, tyrosine and branched chain amino acids varied from 0.8658 to 0.9932 with minor slope biases. This approach also reduced the run time from 120 to 45 min per sample using a sample volume of 0.1 mL, compared to the 0.5 mL volume required for ion-exchange chromatography.
This new approach for the full profile analysis of physiological amino acids has been shown to be a viable substitute for current ion-exchange methodologies. It provides substantial benefits including significant reductions in runtime and necessary sample volume for the investigation and monitoring of patients with metabolic disorders and for nutritional management of a variety of patients.
自 20 世纪 60 年代初以来,传统上一直使用离子交换色谱法和柱后茚三酮衍生化进行定量氨基酸分析(AAA)。这项成熟的技术具有许多优势,包括相对较低的运营成本和易于使用。然而,分析时间长达 120 分钟以上且维护要求高,使得该技术不适合对周转时间要求较高的现代临床实验室。这里描述的工作是我们在全新的生理氨基酸全谱分析方法方面经验的总结。
氨基酸与专有的 AccQTag®试剂分批衍生化,该试剂与伯胺和仲胺反应。衍生化的氨基酸使用超高效液相色谱(UPLC)分离。在一项前瞻性方法比较中,使用 UPLC 方法和传统的离子交换色谱氨基酸分析仪从大约 170 个患者样本中获得的定量血浆氨基酸数据进行了评估。
发现两种方法获得的数据吻合良好。对于在代谢性疾病中常见的苯丙氨酸、酪氨酸和支链氨基酸等重要氨基酸,所得数据的相关系数为 0.8658 至 0.9932,斜率偏差较小。与离子交换色谱所需的 0.5 毫升体积相比,该方法还将每个样本的运行时间从 120 分钟缩短至 45 分钟,样本量为 0.1 毫升。
这种用于生理氨基酸全谱分析的新方法已被证明是当前离子交换方法的可行替代品。它提供了显著的益处,包括分析和监测代谢紊乱患者以及各种患者的营养管理时显著减少运行时间和所需的样本量。